BRISTOL MYERS SQUIBB FDA Approval NDA 009052

NDA 009052

BRISTOL MYERS SQUIBB

FDA Drug Application

Application #009052

Application Sponsors

NDA 009052BRISTOL MYERS SQUIBB

Marketing Status

Discontinued001

Application Products

001POWDER;ORALEQ 500MG BASE/GM0REZIPASAMINOSALICYLIC ACID RESIN COMPLEX

CDER Filings

BRISTOL MYERS SQUIBB
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 9052
            [companyName] => BRISTOL MYERS SQUIBB
            [docInserts] => ["",""]
            [products] => [{"drugName":"REZIPAS","activeIngredients":"AMINOSALICYLIC ACID RESIN COMPLEX","strength":"EQ 500MG BASE\/GM","dosageForm":"POWDER;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"REZIPAS","submission":"AMINOSALICYLIC ACID RESIN COMPLEX","actionType":"EQ 500MG BASE\/GM","submissionClassification":"POWDER;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.